课题基金 / 基金详情

项目摘要

项目成果

Roger T. Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 标题:低收入妇女中肿块切除术(BCS)省略放射治疗的结局 背景:几乎没有描述医疗保健模式和财务结果的信息。 贫困的乳腺癌妇女。在以前的工作中,我们已经开发和验证了一个 将北卡罗来纳州(NC)按服务收费的医疗补助索赔和肿瘤登记数据连接起来的综合数据库, 1998年和1999年的所有病例(N= 1,402),并记录了该数据整合策略的高度有效性, 研究医疗补助中的辅助治疗(放疗和化疗)。我们发现,大约45%的 接受BCS的妇女在诊断日期后12个月内没有接受放射治疗。获得的数据 来自社会保障死亡主文件的数据显示,患有BCS且没有辐射的女性的死亡率是 在随后的中位数72个月内死亡的风险比那些受到辐射的人高, 合并症、分期和手术第一年的死亡。 目标:拟议的是一个为期2年的项目,以确定遗漏辐射与贫困的联系程度 1997-2001年北方地区诊断为乳腺癌的有偿医疗补助妇女的生存率 卡罗莱纳。具体而言,我们建议识别和分析:1)使用索赔的BCS 7年复发率, 采用经验证算法的登记数据; 2)病死率(所有癌症死亡和乳腺癌死亡与所有 其他原因)使用国家死亡指数+系统;以及3)将激素治疗添加到数据集中 使用现有的医疗补助处方索赔来描述访问,并作为复发的预测因素, 生存模式我们将使用回归和生存分析模型来比较BCS(+/-辐射)的发生率 复发和生存率,调整年龄,合并症,肿瘤大小,分期,他莫昔芬处方状态, 激素受体状态 未来方向:我们计划制定社区和卫生系统干预措施,以促进获得 低收入妇女的放射治疗,并调查卫生保健资源的作用, 这一人群中癌症护理基础设施的差异。
英文摘要
ABSTRACT Title: Outcomes of Omission of Radiation With Lumpectomy (BCS) Among Low-Income Women Background: There is little information describing the patterns of health care and outcomes in financially needy women with breast cancer in the United States. In previous work we have developed and validated an integrated database linking North Carolina (NC) fee-for-service Medicaid claims and tumor registry data for all cases in 1998 and 1999 (N=1,402) and documented the high validity of this data integration strategy to study adjuvant treatment (radiation and chemotherapy) in Medicaid. We find that approximately 45% of women who received BCS did not receive radiation within 12 months from date of diagnosis. Data obtained from the Social Security Death Master File showed that women with BCS and no radiation have 1.8 times the risk of dying during the subsequent median 72 month period than those who were radiated, adjusting for comorbidity, stage, and deaths in first year of surgery. Objectives: Proposed is a 2-year project to ascertain the extent that omission of radiation is linked to poorer survival in women with fee-for-service Medicaid diagnosed with breast cancer in years 1997-2001 in North Carolina. Specifically, we propose to identify and analyze: 1) 7-year recurrence with BCS using claims and registry data with a validated algorithms; 2) case-fatality (all cancer deaths, and breast cancer deaths vs all other causes) using the National Death Index Plus system; and 3) to add hormonal therapy to the dataset using existing Medicaid prescription claims to describe access and as a predictor in the recurrence and survival models. We will use regression and survival analytic models to compare rates of BCS (+/- radiation) on recurrence and survival, adjusting for age, comorbidity, tumor size, stage, tamoxifen prescription status, hormone receptor status. Future Directions: We plan to develop community and health systems interventions to promote access to radiotherapy among low income women, and investigate the role of health care resources and Infrastructure on cancer care disparities in this population.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
  • 批准号:
    10381628
  • 项目类别:
  • 资助金额:
    $194.66万
  • 财政年份:
    2019
  • 负责人:
    Roger T. Anderson
  • 依托单位:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
  • 批准号:
    10524229
  • 项目类别:
  • 资助金额:
    $4.27万
  • 财政年份:
    2019
  • 负责人:
    Roger T. Anderson
  • 依托单位:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
  • 批准号:
    10524070
  • 项目类别:
  • 资助金额:
    $13.24万
  • 财政年份:
    2019
  • 负责人:
    Roger T. Anderson
  • 依托单位:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
  • 批准号:
    9913491
  • 项目类别:
  • 资助金额:
    $225.62万
  • 财政年份:
    2019
  • 负责人:
    Roger T. Anderson
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: